《缺血性卒中/TIA二级预防中抗血小板药物规范化应用的中国专家共识》 氯吡格雷(75mg/d)、阿司匹林(50-325 mg/d),缓释双嘧达莫(200mg)与阿司匹林(25mg)复发制剂(2次/d)均可作为首选的抗血小板药物(Ⅰ,A)。 依据各种抗血小板治疗药物的获益、相应风险及费用进行个体化治疗(Ⅱa, C)。 中华内科杂志2009年3月...
MATCH研究增加致命性出血,发生于联合用药三个月之后SPS3:针对皮层下脑梗死(小血管病)的长期联合:显著增加大出血 2014中国缺血性脑卒中和TIA二级预防指南2014指南推荐意见:阿司匹林(50-325mg/d)或氯吡格雷(75mg/d)单药治疗均可以作为首选抗血小板药物(I类推荐,A级证据)。阿司匹林单药抗血小板治疗的最佳剂量为75-...
Acute Renal Failure in Obstetrics, Is It Really a Prognostic Factor?tests and Student t test corrected by Fisher exact test. P<0,05 was considered significant. Univariate analysis determined risk factors for ARF development. All potential risk factors for ARF development with p≤0,2 were ...